Delivery Order SPE2DB22D2206-SPE2DB24FGE09
Award Date 3/19/24
Potential Completion Date 4/9/24
Potential Value $37K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $36,698.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of POMALYST 3 MG CAPSULE 21S, a pharmaceutical product, with a completion date of May 14, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Pomalyst 3 mg capsules. The contract has a potential value of $12,232.76 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for the company...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide POMALYST 4 MG CAPSULE 100S. The $230,031.96 contract has a completion date of September 8, 2021 and does not have a set-aside designation. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution...
- This is a $114,147.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pomalyst 1 mg capsules, a specialty medication used for the treatment of certain types of cancer. The contract has a period of performance through January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pomalyst 4 mg capsules (21-count units) with a ceiling value of $41,555.25. This firm fixed price delivery order, with an ultimate completion date of September 10, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $12,287.90 firm-fixed-price delivery order is for the supply of POMALYST 2 MG CAPSULE 21S, a prescription medication. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,781,412 units of the pharmaceutical product POMALYST 3 MG CAPSULE 100S. The $162,093.60 contract was awarded on April 4, 2022 with a completion date of April 25, 2022. Amerisourcebergen Drug Corp, which has an existing indefinite delivery contract with the Department of Justice Federal...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $12,084.50, this order is for the supply of 4562914807 POMALYST 4 MG CAPSULE 21S to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 18, 2023. No set-aside designation was applied to this award. As a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distributor. The order, valued at $7,792.08, is for the supply of 125 mg Ibrance capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a $26,566.44 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product, with an ultimate completion date of August 6, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive...